Clinical Trial Update: Clonal Hematopoiesis of Indeterminate Potential in Heart Failure.

View source ↗

Summary

A clinical trial is evaluating clonal hematopoiesis of indeterminate potential (CHIP) in patients with heart failure and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | Conditions: Heart Failure | Status: RECRUITING